Cargando…
Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
Several conflicting results regarding the efficacy of 0.01% atropine in slowing axial elongation remain in doubt. To solve this issue and evaluate the safety of 0.01% atropine, we conducted a systematic review and meta-analysis with the latest evidence. The review included a total of 1178 participan...
Autores principales: | Tsai, Hou-Ren, Chen, Tai-Li, Wang, Jen-Hung, Huang, Huei-Kai, Chiu, Cheng-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432260/ https://www.ncbi.nlm.nih.gov/pubmed/34501214 http://dx.doi.org/10.3390/jcm10173766 |
Ejemplares similares
-
Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022) -
Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022) -
Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021) -
Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study)
por: Agarwal, Pradeep, et al.
Publicado: (2022) -
Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)